Clearmind Medicine Inc. (CMND) NASDAQ
2.91
-0.01(-0.34%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.91
-0.01(-0.34%)
Currency In USD
| Market Cap | 404.41M |
| Enterprise Value | 402.27M |
| P/E Ratio | -0.51 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.99 |
| Fiscal Year | October 31, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.6 |
| Return On Equity | -1.82 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -49,364 |
| EBITDA | -3.72M |
| Net Income | -3.86M |
| Diluted EPS | -3.03 |
| Total Cash | 10.34M |
| Total Cash/Share | 8.9 |
| Total Debt | 7,971 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.79 |
| Book Value Per Share | 7.08 |
| 52-Week Change | -99.23 |
| 52-Week High | 524 |
| 52-Week Low | 2.1 |
| Moving Average 50 Days | 7.04 |
| Moving Average 200 Days | 135.89 |
| Average Volume | 1.34M |
| Shares Outstanding | 1.02M |
| % Held by Institutions | 3.87 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 21, 2026 |